96998-53-7

Upstream product

• 4167-02-6 2-bromoethylphosphoric acid dichloride 
• 84415-90-7 (R)-2-benzyloxy-3-hexadecyloxy-propan-1-ol 
• 75-50-3 trimethylamine 
• 17674-16-7 benzyl triflate 
• 10550-58-0 (R)-3-(hexadecyloxy)-1,2-propanediol 
• 55357-38-5 choline tosylate 
• 100-51-6 benzyl alcohol 
• 122564-58-3 3-O-hexadecyl-2-O-benzyl-sn-glycerol 1-O-p-toluenesulfonate 
• 119944-30-8 3‐hexadecyloxy‐2R‐hydroxyl propyl‐1‐p‐toluene sulphonate 
• 121469-38-3 1-O-hexadecyl-2-O-benzyl-sn-glycerol 3-O-p-toluenesulfonate 
• 120019-37-6 3-hexadecyloxy-2R-hydroxypropyl 1-para-toluenesulphonate 
• 36653-82-4 1-Hexadecanol 
• 84379-59-9 2-O-benzyl-1-O-hexadecyl-3,4-O-isopropylidene-L-threitol 
• 84379-61-3 2-O-benzyl-1-O-hexadecyl-L-threitol 

Downstream Products

• 90130-75-9 3-O-hexadecyl-2-lyso-sn-glycero-1-phosphocholine 
• 78119-19-4 2-hydroxy-3-(hexadecyloxy)-propyl 2-trimethylammonioethyl phosphate 

Relevant academic research and scientific papers

An Efficient Stereocontrolled Route to Both Enantiomers of Platelet Activating Factor and Analogues with Long-Chain Esters at C2: Saturated and Unsaturated Ether Glycerolipids by Opening of Glycidyl Arenesulfonates

Both enantiomers of various ether/ester glycerophospholines (R)- and (S)-1, including platelet activating factor (PAF, 2), have been synthesized from arenesulfonate derivatives of glycidol ((R)- and (S)-3) that are readily available in high enantiomeric p

NOVEL ENANTIOSELECTIVE SYNTHESIS OF PLATELET ACTIVATING FACTOR AND ITS ENANTIOMER VIA RING OPENING OF GLYCIDYL TOSYLATE WITH 1-HEXADECANOL

(2R)-and(2S)-Glycidyl tosylates 3 and 3' were used to synthesize platelet activating factor 1 and its enantiomer 2 in very high optical purity via the ring-opened ether-linked glycerol tosylate 4 and 4'